Canada’s decision to suspend the use of the AstraZeneca-Oxford vaccine in Canadians under 55 during a surging third wave and a slow vaccination rollout is a calculated risk.
Why restricting AstraZeneca vaccines in Canada means balancing ‘vaccine risk vs. disease risk’
